Skip to main content
Clinical Trials/CTRI/2023/05/053118
CTRI/2023/05/053118Not yet recruitingPhase 3

Randomized open controlled clinical study to evaluate the sodhan and ropan effect of tilakalkadi lepa in dushta vrana with special reference to infected wound.

Dr Shekhar0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1 Patient having sign and symptoms of Dushtavrana(infected wound).
  • 2 Having area less then 5cm length,5cm width and 3cm depth.
  • 3 Patient having control diabetes.

Exclusion Criteria

  • 1 Known cases of HIV,Hepatitis B, any systemic disease except diabetes.
  • 2 Patients suffering from wounds like:-
  • -Excessive lose of tissue.
  • -Tubercular ulcers.
  • -Venous ulcers.
  • -Malignant ulcers.

Investigators

Sponsor
Dr Shekhar

Similar Trials